RCM Technologies (RCMT) Q2 2024 earnings summary

Executive summary

• Revenue for Q2 2024 increased 3.2% year-over-year to $69.2 million, with gross profit up 6.6% to $20.0 million and net income of $3.8 million ($0.47 per diluted share).

• Adjusted EBITDA for Q2 2024 rose 10.8% year-over-year to $7.2 million, and adjusted diluted EPS increased to $0.56 from $0.50.

• Engineering led Q2 growth, with project activity ramping up and strong contributions expected from all divisions in the second half of the year.

• The company has transitioned from a healthcare-centric model to a diversified professional services platform, with engineering now a key growth driver.

• Gross profit margin improved to 28.9% from 28.0% year-over-year, and the company remains focused on expanding higher-margin services and investing in sales and recruiting infrastructure.

Financial highlights

• Q2 2024 revenue was $69.2M (+3.2% YoY); gross profit was $20.0M (+6.6% YoY).

• Adjusted EBITDA for Q2 2024 was $7.2M, up from $6.5M year-over-year.

• Adjusted diluted EPS for Q2 2024 rose 12.0% year-over-year, from $0.50 to $0.56.

• School revenue for Q2 2024 grew 23.0% year-over-year (excluding COVID impact), reaching $30.8M.

• Cash provided by operating activities for the first half of 2024 was $12.2M, down from $16.5M in the prior-year period.

Outlook and guidance

• Low double-digit consolidated adjusted EBITDA growth is expected for the second half of 2024 compared to 2023.

• Optimism for continued strong performance in engineering and increased strength in healthcare and life sciences in the back half of the year.

• The pipeline for new school contracts is at a record high, with over 20 new districts signed for 2024/2025.

• Management expects continued growth in school client revenue within Specialty Health Care, supported by recent investments in sales and recruiting.

• Ongoing ERP system upgrades and process improvements are expected to enhance operational efficiency.